Atea Pharmaceuticals Ownership | Who Owns Atea Pharmaceuticals?
Atea Pharmaceuticals Ownership Summary
Atea Pharmaceuticals is owned by 68.59% institutional investors, 9.67% insiders, and 21.73% retail investors. Blackrock is the largest institutional shareholder, holding 10.87% of AVIR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.49% of its assets in Atea Pharmaceuticals shares.
AVIR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Atea Pharmaceuticals | 68.59% | 9.67% | 21.73% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 9.12M | 10.87% | $30.19M |
Fmr | 6.44M | 7.67% | $21.30M |
Bml capital management | 6.38M | 7.60% | $21.10M |
Ecor1 capital | 5.44M | 6.48% | $18.01M |
Vanguard group | 4.72M | 5.63% | $15.64M |
Tang capital management | 4.48M | 5.33% | $14.82M |
Bain capital life sciences investors | 2.49M | 2.96% | $8.23M |
Geode capital management | 2.01M | 2.40% | $6.65M |
State street | 1.72M | 2.05% | $5.70M |
Almitas capital | 1.29M | 1.54% | $4.27M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Bml capital management | 6.38M | 15.06% | $21.10M |
Almitas capital | 1.29M | 1.78% | $4.27M |
Tang capital management | 4.48M | 1.51% | $14.82M |
Bain capital life sciences investors | 2.49M | 0.90% | $8.23M |
Cm management | 270.00K | 0.82% | $893.70K |
Ecor1 capital | 5.44M | 0.55% | $18.01M |
Acuitas investments | 259.29K | 0.46% | $858.25K |
Newtyn management | 380.00K | 0.24% | $1.26M |
Auour investments | 177.00K | 0.22% | $585.87K |
Rbf capital | 148.45K | 0.03% | $491.37K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Almitas capital | 1.29M | 1.78% | 1.29M |
Bml capital management | 6.38M | 15.06% | 838.91K |
Fmr | 6.44M | 0.00% | 657.09K |
Tang capital management | 4.48M | 1.51% | 400.00K |
Dimensional fund advisors lp | 594.36K | 0.00% | 211.43K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | 5.44M | 0.55% | -703.97K |
Millennium management | - | - | -212.76K |
Marshall wace, llp | - | - | -182.33K |
Blackrock | 9.12M | 0.00% | -122.74K |
Susquehanna group, llp | 67.55K | - | -117.86K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Almitas capital | 1.29M | 1.78% | 1.29M | $4.27M |
Verition fund management | 65.98K | 0.00% | 65.98K | $218.38K |
Berkshire asset management llc/pa | 65.00K | 0.01% | 65.00K | $215.15K |
Corebridge financial | 41.51K | 0.00% | 41.51K | $137.41K |
Mirae asset global etfs | 39.05K | 0.00% | 39.05K | $129.25K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -15.00 |
Federation des caisses desjardins du quebec | -24.00 |
Colonial trust advisors | -46.00 |
Smartleaf asset management | -46.00 |
Northwestern mutual wealth management | -75.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 108 | 1.89% | 57,907,511 | 2.15% | 68 | 1.50% | 54 | 14.89% | 28 | -24.32% |
Jun 30, 2024 | 106 | -8.62% | 56,687,791 | 4.35% | 67 | 1.59% | 47 | -11.32% | 37 | -5.13% |
Mar 31, 2024 | 116 | 3.57% | 54,324,574 | -1.24% | 65 | 1.50% | 53 | -5.36% | 39 | 34.48% |
Dec 31, 2023 | 112 | -8.20% | 55,005,563 | -3.18% | 65 | 1.42% | 56 | 12.00% | 29 | -27.50% |
Sep 30, 2023 | 122 | -10.95% | 56,813,287 | -0.44% | 68 | 1.45% | 50 | -26.47% | 40 | 2.56% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 3.79M | 4.49% | 60.75K |
Fidelity Growth Compy Commingled Pl O | 3.73M | 4.42% | 23.40K |
Vanguard Total Stock Mkt Idx Inv | 2.36M | 2.80% | - |
iShares Russell 2000 ETF | 1.98M | 2.34% | -4.45K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.27M | 1.50% | -9.17K |
Fidelity Growth Company Fund | 946.47K | 1.12% | 33.75K |
Fidelity Select Biotechnology | 921.47K | 1.09% | -36.83K |
Fidelity Small Cap Index | 769.60K | 0.91% | -16.52K |
Fidelity Growth Company K6 | 749.96K | 0.89% | -2.20K |
iShares Russell 2000 Value ETF | 736.40K | 0.87% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 10, 2024 | BERGER FRANKLIN M | - | Sell | $1.02M |
Sep 19, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | Sell | $7.37K |
Sep 18, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | Sell | $89.47K |
Sep 17, 2024 | Sommadossi Jean-Pierre | President, CEO, and Chairman | Sell | $137.32K |
Jun 20, 2024 | Polsky Bruce | - | Sell | $61.14K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 1 |
2024 Q3 | - | 3 |
2024 Q2 | - | 2 |
2024 Q1 | - | 6 |
2023 Q2 | - | - |
AVIR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools